4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-013383
CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)
- CHIEF OPERATING OFFICER acquired 1,107 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-14 | Option exercise 10b5-1 | +1,107 | $2.48 | $2,745 | 1,107 | D: show line 1 in the form |
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-14 | Sale 10b5-1 | −1,107 | $25.00 | $27,675 | 0 | D: show line 2 in the form |
| Open-market sales · 1,107 sh · avg $25.00 · $27,675 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2024-05-14 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,107 | 54,475 | D: show line 3 in the form |
Loading xslF345X05/form4-05162024_110525.xml…